BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng Y, Zeng Y, Yin H, Chen F, Wang Q, Yu X, Zhou Y. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma. Aging (Albany NY) 2021;13:3459-82. [PMID: 33428606 DOI: 10.18632/aging.202279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Zhou Z, Ma L, Li C, Lin Y, Yu T, Wei JF, Zhu L, Yao G. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma. Cancer Cell Int 2021;21:453. [PMID: 34446007 DOI: 10.1186/s12935-021-02163-9] [Reference Citation Analysis]
2 Liu D, Yang X, Wu X. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Front Immunol 2021;12:663495. [PMID: 34025664 DOI: 10.3389/fimmu.2021.663495] [Reference Citation Analysis]
3 Yan M, Hu J, Ping Y, Xu L, Liao G, Jiang Z, Pang B, Sun S, Zhang Y, Xiao Y, Li X. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma. Front Immunol 2021;12:758288. [PMID: 34804045 DOI: 10.3389/fimmu.2021.758288] [Reference Citation Analysis]
4 Yuan Y, Zhu Z, Lan Y, Duan S, Zhu Z, Zhang X, Li G, Qu H, Feng Y, Cai H, Song Z. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Front Immunol 2021;12:659444. [PMID: 34040608 DOI: 10.3389/fimmu.2021.659444] [Reference Citation Analysis]